VCAM-1: closing the gap between lipotoxicity and endothelial dysfunction in nonalcoholic steatohepatitis

VCAM-1: closing the gap between lipotoxicity and endothelial dysfunction in nonalcoholic steatohepatitis

Nonalcoholic fatty liver illness (NAFLD) outcomes in the accumulation of fats in the liver and can progress as an inflammatory dysfunction with appreciable vascular endothelial dysfunction referred to as nonalcoholic steatohepatitis (NASH). Inflammatory alerts can set off the expression of vascular cell adhesion molecule 1 (VCAM-1) on endothelial cells. VCAM-1 is a floor protein that induces adherence … Read more